Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

BACKGROUND: Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Felisiak-Golabek, Anna, Rembiszewska, Alina, Rzepecka, Iwona K, Szafron, Lukasz, Madry, Radoslaw, Murawska, Magdalena, Napiorkowski, Tomasz, Sobiczewski, Piotr, Osuch, Beata, Kupryjanczyk, Jolanta
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223127/
https://ncbi.nlm.nih.gov/pubmed/22075440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-4-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados